Suchergebnisse - "Edoardo Mannucci"

PubPharm (21)

1

Autologous Peripheral Blood Mononuclear Cells in Patients with Small Artery Disease and Diabetic Foot Ulcers: Efficacy, Safety, and Economic Evaluation

in: Journal of Clinical Medicine | 2023

von Benedetta Ragghianti | Bianca Maria Berardi | Edoardo Mannucci | +1

2

Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus

in: Cardiovascular Diabetology | 2022

von Carlo Di Mario | Stefano Genovese | Gaetano A. Lanza | +5

3

Adherence to and early adverse events of COVID-19 vaccine in a cohort of 600 Italian breastfeeding and pregnant physicians

in: Human Vaccines & Immunotherapeutics | 2022

von Marco Montalti | Federica Guaraldi | Zeno Di Valerio | +5

4

Impact of Influenza Vaccination on All-Cause Mortality and Hospitalization for Pneumonia in Adults and the Elderly with Diabetes: A Meta-Analysis of Observational Studies

in: Vaccines | 2020

von Angela Bechini | Alessandra Ninci | Marco Del Riccio | +5

5

Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy

in: International Journal of Infectious Diseases | 2020

von Edoardo Mannucci | Besmir Nreu | Matteo Monami

6

Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes

in: Farmeconomia: Health Economics and Therapeutic Pathways | 2020

von Edoardo Mannucci | Pier Paolo Mangia | Lorenzo Pradelli

7

Effect of Dipeptidyl-Peptidase 4 Inhibitors on Circulating Oxidative Stress Biomarkers in Patients with Type 2 Diabetes Mellitus

in: Antioxidants | 2020

von Elisabetta Bigagli | Cristina Luceri | Ilaria Dicembrini | +5

8

A case of malignant insulinoma responsive to somatostatin analogs treatment

in: BMC Endocrine Disorders | 2018

von Mariasmeralda Caliri | Valentina Verdiani | Edoardo Mannucci | +7

9

Cost-effectiveness analysis of empagliflozin in the treatment of patients with type 2 diabetes and established cardiovascular disease in Italy, based on the results of the EMPA-REG OUTCOME study

in: Farmeconomia: Health Economics and Therapeutic Pathways | 2017

von Sergio Iannazzo | Edoardo Mannucci | Odette Reifsnider | +1

10

Budget impact analysis of empagliflozin in T2D patients with a previous cardiovascular disease

in: Global & Regional Health Technology Assessment | 2017

von Sergio Iannazzo | Aldo Pietro Maggioni | Edoardo Mannucci